| Issue Date | Title | Author(s) |
| Nov-2020 | Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System | Wang, Fuzhen; Sun, Xiaojin; Wang, Feng; Zheng, Hui; Jia, Zhiyuan; Zhang, Guomin; Bi, Shengli; Miao, Ning; Zhang, Shuang; Cui, Fuqiang; Li, Li; Wang, Huaqing; Liang, Xiaofeng; Rodewald, Lance E.; Feng, Zijian; Yin, Zundong; Shen, Liping |
| Mar-2020 | An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202) | Wang, Xiang; Zhang, Ruixing; Du, Nan; Yang, Mudan; Zang, Aimin; Liu, Likun; Yu, Junyan; Gao, Jinghua; Zhang, Junping; Fu, Zhanzhao; Ren, Yuchuan; Ma, Liwen; Guo, Jun; Li, Qingshan; Li, Xiaomei; Fan, Zaiwen; Song, Xiang; Liu, Zheng; Zhang, Yan; Li, Guozhong; Yu, Zhonghe; Diao, Jianfeng; Jia, Junmei; Liang, Feng; Wang, Huaqing; Sun, Junzhong; Gao, Yunge; Yang, Ping; Bai, Chunmei; Ren, Xiubao; Zhong, Diansheng |
| 15-Jul-2020 | Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20(+) B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study | Jiang, Bo; Ke, Xiaoyan; Zhang, Qingyuan; Xu, Wei; Su, Hang; Huang, Jie; Zhang, Mingzhi; Wang, Huaqing; Jin, Chuan; Zhu, Jun; Liu, Li; Cai, Zhen; Zhao, Xielan; Zhou, Jianfeng; Zhang, Xiaohong; Liu, Jing; Zhou, Hui; Yu, Jie; Sun, Xing; Qi, Junyuan; Qiu, Lugui |
| 16-Apr-2020 | A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma | Shi, Yuankai; Song, Yongping; Qin, Yan; Zhang, Qingyuan; Han, Xiaohong; Hong, Xiaonan; Wang, Dong; Li, Wei; Zhang, Yang; Feng, Jifeng; Yang, Jianmin; Zhang, Huilai; Jin, Chuan; Yang, Yu; Hu, Jianda; Wang, Zhao; Jin, Zhengming; Su, Hang; Wang, Huaqing; Yang, Haiyan; Fu, Weijun; Zhang, Mingzhi; Zhang, Xiaohong; Chen, Yun; Ke, Xiaoyan; Liu, Li; Yu, Ding; Chen, Guo'an; Wang, Xiuli; Jin, Jie; Sun, Tao; Du, Xin; Cheng, Ying; Yi, Pingyong; Zhao, Xielan; Ma, Chaoming; Cheng, Jiancheng; Chai, Katherine; Luk, Alvin; Liu, Eugene; Zhang, Xin |
| 2017 | Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China | Cui, Fuqiang; Shen, Lipin; Li, Li; Wang, Huaqing; Wang, Fuzhen; Bi, Shengli; Liu, Jianhua; Zhang, Guomin; Wang, Feng; Zheng, Hui; Sun, Xiaojin; Miao, Ning; Yin, Zundong; Feng, Zijian; Liang, Xiaofeng; Wang, Yu |
| 2020 | Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202) | Wang, Xiang; Yu, Junyan; Yang, Mudan; Liu, Likun; Gao, Jinghua; Ren, Yuchuan; Zhang, Ruixing; Zhong, Diansheng; Du, Nan; Fu, Zhanzhao; Jia, Junmei; Li, Qingshan; Diao, Jianfeng; Zhang, Junping; Guo, Jun; Li, Xiaomei; Song, Xiang; Zhang, Yan; Yu, Zhonghe; Ma, Liwen; Fan, Zaiwen; Liu, Zheng; Li, Guozhong; Liang, Feng; Wang, Huaqing; Gao, Yunge; Yang, Ping; Bai, Chunmei; Zang, Aimin; Ren, Xiubao |
| 11-Dec-2020 | Vaccine-Associated Paralytic Poliomyelitis-8 PLADs, China, October 2012-March 2014 | Wen, Ning; Fang, Fang; Xu, Wenbo; Wang, Huaqing; Zhang, Yong; Su, Qiru; Liu, Yao; Wang, Haibo; Zhu, Shuangli; Zhang, Xiaoxiao; Yu, Wenzhou; Yan, Dongmei; Zhang, Zhenguo; Tan, Qiu; Ma, Fubao; Dong, Aihu; Liu, Yu; Li, Keli; Zheng, Li; Hao, Lixin; Wang, Dongyan; Fan, Chunxiang; Wu, Wendi; Luo, Huiming; Xu, Aiqiang; Yang, Weizhong |
